Table Graph
      published meta-analysis   sensitivity analysis   studies

control in COVID-19 prophylaxis (children) - Summary of results

OutcomeTE95% CInkI2ROBPub. bias confirmed Covid-19, from 1st dosedetailed resultsC4591001 (Adolescents 12-25), 2021 (REV) 11.90 [2.93; 48.45] 11.90[2.93; 48.45]C4591001 (Adolescents 12-25), 2021 (REV)10%2,260NAnot evaluable symptomatic Covid-19detailed resultsOut of scaleC4591001 (Adolescents 12-25), 2021 (REV) 33.41 [2.00; 558.46] 33.41[2.00; 558.46]C4591001 (Adolescents 12-25), 2021 (REV)10%1,983NAnot evaluable vaccine efficacy after dose 1 (and before dose 2)detailed resultsC4591001 (Adolescents 12-25), 2021 (REV) 4.02 [0.89; 18.20] 4.02[0.89; 18.20]C4591001 (Adolescents 12-25), 2021 (REV)10%2,239NAnot evaluable0.520.01.0relative treatment effectwww.metaEvidence.org2024-06-02 19:18 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 330 - treatments: 649,650,589,651,968 - roots T: 290

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons